What is the safest way to taper off 0.25mg of clonazepam (Klonopin)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safely Tapering Off 0.25mg Clonazepam

The safest way to taper off 0.25mg clonazepam is to reduce the dose by approximately 10% of the most recent dose per week, which would mean reducing by about 0.025mg weekly until discontinuation. 1

Tapering Schedule for 0.25mg Clonazepam

For a low dose of 0.25mg clonazepam, a gradual taper is essential to minimize withdrawal symptoms:

  • Week 1-2: Reduce by 0.025mg (to 0.225mg)
  • Week 3-4: Reduce by 0.025mg (to 0.2mg)
  • Week 5-6: Reduce by 0.02mg (to 0.18mg)
  • Week 7-8: Reduce by 0.02mg (to 0.16mg)
  • Week 9-10: Reduce by 0.015mg (to 0.145mg)
  • Week 11-12: Reduce by 0.015mg (to 0.13mg)
  • Week 13-14: Reduce by 0.015mg (to 0.115mg)
  • Week 15-16: Reduce by 0.01mg (to 0.105mg)
  • Week 17-18: Reduce by 0.01mg (to 0.095mg)
  • Week 19-20: Reduce by 0.01mg (to 0.085mg)
  • Week 21-22: Reduce by 0.01mg (to 0.075mg)
  • Week 23-24: Reduce by 0.0075mg (to 0.0675mg)
  • Week 25-26: Reduce by 0.0075mg (to 0.06mg)
  • Week 27-28: Reduce by 0.005mg (to 0.055mg)
  • Week 29-30: Reduce by 0.005mg (to 0.05mg)
  • Week 31-32: Reduce by 0.005mg (to 0.045mg)
  • Week 33-34: Reduce by 0.0025mg (to 0.0425mg)
  • Week 35-36: Reduce by 0.0025mg (to 0.04mg)
  • Week 37-38: Reduce by 0.0025mg (to 0.0375mg)
  • Week 39-40: Reduce by 0.0025mg (to 0.035mg)
  • Week 41-42: Reduce by 0.0025mg (to 0.0325mg)
  • Week 43-44: Reduce by 0.0025mg (to 0.03mg)
  • Week 45-46: Reduce by 0.0025mg (to 0.0275mg)
  • Week 47-48: Reduce by 0.0025mg (to 0.025mg)
  • Week 49-50: Reduce by 0.0025mg (to 0.0225mg)
  • Week 51-52: Reduce by 0.0025mg (to 0.02mg)
  • Week 53-54: Reduce by 0.002mg (to 0.018mg)
  • Week 55-56: Reduce by 0.002mg (to 0.016mg)
  • Week 57-58: Reduce by 0.002mg (to 0.014mg)
  • Week 59-60: Reduce by 0.002mg (to 0.012mg)
  • Week 61-62: Reduce by 0.002mg (to 0.01mg)
  • Week 63-64: Reduce by 0.002mg (to 0.008mg)
  • Week 65-66: Reduce by 0.002mg (to 0.006mg)
  • Week 67-68: Reduce by 0.002mg (to 0.004mg)
  • Week 69-70: Reduce by 0.002mg (to 0.002mg)
  • Week 71-72: Reduce by 0.002mg (discontinue)

Monitoring and Managing Withdrawal Symptoms

During the tapering process, monitor for these common withdrawal symptoms:

  • Anxiety
  • Shaking/trembling
  • Nausea/vomiting
  • Insomnia/nightmares
  • Excessive sweating
  • Tachycardia/palpitations
  • Headache
  • Weakness
  • Muscle aches 2

If withdrawal symptoms become problematic:

  1. Temporarily pause the taper at the current dose until symptoms resolve
  2. Resume with a slower taper rate (5% instead of 10% reductions)
  3. Consider adjunctive treatments for specific symptoms 1

Adjunctive Treatments for Withdrawal Symptoms

For managing specific withdrawal symptoms, consider:

  • Insomnia: Trazodone, mirtazapine, or gabapentin
  • Anxiety: Hydroxyzine or gabapentin
  • Pain: Acetaminophen (not exceeding 3000mg daily) or NSAIDs
  • Gastrointestinal symptoms: Loperamide 1

Non-Pharmacological Approaches

Incorporate these strategies to support the tapering process:

  • Cognitive behavioral therapy
  • Regular exercise
  • Sleep hygiene practices
  • Stress management techniques 1

Special Considerations

  1. Long-term users (>1 year): Consider an even slower taper of 5% per month rather than 10% per week 1

  2. Elderly patients: Require slower tapering (5% reductions) and more frequent monitoring 1

  3. Pregnancy: Consult specialist expertise before tapering due to risks to both mother and fetus 1

  4. Severe symptoms: If withdrawal symptoms become severe, it is appropriate to pause the taper temporarily and resume at a slower rate 3

Research has shown that slower tapering over months is associated with better outcomes than quicker tapering over weeks, particularly for preventing relapse and minimizing withdrawal symptoms 3. The evidence from studies on clonazepam specifically suggests that gradual tapering is generally successful without major withdrawal symptoms 2.

References

Guideline

Baclofen Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.